[go: up one dir, main page]

GB1453035A - Virus vaccine production - Google Patents

Virus vaccine production

Info

Publication number
GB1453035A
GB1453035A GB5914672A GB5914672A GB1453035A GB 1453035 A GB1453035 A GB 1453035A GB 5914672 A GB5914672 A GB 5914672A GB 5914672 A GB5914672 A GB 5914672A GB 1453035 A GB1453035 A GB 1453035A
Authority
GB
United Kingdom
Prior art keywords
virus
cell suspension
encephalites
suspension
eggs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5914672A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SECR DEFENCE
UK Secretary of State for Defence
Original Assignee
SECR DEFENCE
UK Secretary of State for Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SECR DEFENCE, UK Secretary of State for Defence filed Critical SECR DEFENCE
Priority to GB5914672A priority Critical patent/GB1453035A/en
Publication of GB1453035A publication Critical patent/GB1453035A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24151—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

1453035 Virus vaccines DEFENCE SECRETARY OF STATE FOR 20 March 1974 [21 Dec 1972] 59146/72 Heading A5B Virus vaccines are prepared by preparing an embryo cell suspension directly from incubated embryonated avian eggs, infecting the cell suspension so produced with the appropriate virus, culturing the virus in deep culture in the infected cell suspension, separating the resulting virus from the cell debris and, if necessary, processing the separated virus to give a vaccine. The "direct" preparation of the cell suspension requires that the suspension should contain substantially only cells which were present in the eggs. The virus may be that of tick-borne encephalites, Japanese B encephalites, louping-ill and yellow fever.
GB5914672A 1972-12-21 1972-12-21 Virus vaccine production Expired GB1453035A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB5914672A GB1453035A (en) 1972-12-21 1972-12-21 Virus vaccine production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5914672A GB1453035A (en) 1972-12-21 1972-12-21 Virus vaccine production

Publications (1)

Publication Number Publication Date
GB1453035A true GB1453035A (en) 1976-10-20

Family

ID=10483155

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5914672A Expired GB1453035A (en) 1972-12-21 1972-12-21 Virus vaccine production

Country Status (1)

Country Link
GB (1) GB1453035A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2950004A1 (en) * 1978-12-22 1980-07-03 Immuno Ag METHOD FOR PRODUCING EARLY SUMMER MENINGOENZEPHALITIS VIRUS (TBE VIRUS) VACCINES
FR2532548A1 (en) * 1982-09-03 1984-03-09 Pasteur Institut NOVEL PROCESS FOR THE PRODUCTION OF VACCINES HAVING A HIGH TITLE OF VIRUSES AND HIGHLY PURIFIED VACCINES, A HIGH TITLE OF VIRUSES, SO OBTAINED

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2950004A1 (en) * 1978-12-22 1980-07-03 Immuno Ag METHOD FOR PRODUCING EARLY SUMMER MENINGOENZEPHALITIS VIRUS (TBE VIRUS) VACCINES
FR2532548A1 (en) * 1982-09-03 1984-03-09 Pasteur Institut NOVEL PROCESS FOR THE PRODUCTION OF VACCINES HAVING A HIGH TITLE OF VIRUSES AND HIGHLY PURIFIED VACCINES, A HIGH TITLE OF VIRUSES, SO OBTAINED

Similar Documents

Publication Publication Date Title
ATE7855T1 (en) PRODUCTION OF VIRUS ANTIGENS.
GB1292803A (en) Improvements relating to the production of antigens
GB1486186A (en) Vaccines against feline leukaemia and the group of diseases associated with feline leukaemis/virus infection
Hirst et al. A new method for concentrating influenza virus from allantoic fluid
ES8104405A1 (en) Influenza virus vaccines, process for preparing them and process for propagating influenza viruses.
Holtermann et al. The development of soluble (S) and viral (V) antigens of influenza A virus in tissue culture as studied by the fluorescent antibody technique. 1. Studies employing a low multiplicity of infection in beef embryo kidney cells
GB1453035A (en) Virus vaccine production
GB1317710A (en) Poultry vaccine
ES8107025A1 (en) Attenuated strain of feline infectious peritonitis virus, method for preparing it and vaccine comprising it.
ES430415A1 (en) Live influenza virus vaccines and preparation thereof
GB1488800A (en) Influenza vaccines
Takemoto et al. Influence of acid polysaccharides on plaque formation by influenza A2 and B viruses
Howie Spawning mechanism in the male lugworm
GB1358321A (en) Method od tissue cell culture
GB1143996A (en) Antiviral vaccine
ES8107024A1 (en) Feline infectious peritonitis vaccine and process for its preparation.
GB1270918A (en) Preparation of multivalent vaccines
GB1279859A (en) Process for the production of enhanced levels of viral yield
GB1133958A (en) Process for the manufacture of a distemper vaccine
GB1481650A (en) Chemical processes and products
GB1436323A (en) Cell and virus culture systems
ES410357A1 (en) Process for the cultivation of virus-infected fungi
GB1355259A (en) Attenuated rubella virus vaccine and production thereof
GB1481847A (en) Vaccine for marek's disease of poultry
GB1349362A (en) Process for preparing live virus vaccines

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee